Trial
NCT00727532
Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
National Cancer Institute (NCI)
Condition
Hereditary Clear Cell Renal Cell Carcinoma
Intervention
Sorafenib
Why stopped
Low Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-03